Detailed answers about NUCLIDE THERAPEUTICS LTD, including incorporation, status, business activity, and accounts information.
When was NUCLIDE THERAPEUTICS LTD founded?
NUCLIDE THERAPEUTICS LTD was officially incorporated on 22 May 2024 and is registered under company number 15734758. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NUCLIDE THERAPEUTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NUCLIDE THERAPEUTICS LTD?
NUCLIDE THERAPEUTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NUCLIDE THERAPEUTICS LTD do?
NUCLIDE THERAPEUTICS LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NUCLIDE THERAPEUTICS LTD's registered address?
The registered office address of NUCLIDE THERAPEUTICS LTD is 124 CITY ROAD, LONDON, UNITED KINGDOM, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is NUCLIDE THERAPEUTICS LTD financially stable?
The most recent accounts for NUCLIDE THERAPEUTICS LTD were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.
Does NUCLIDE THERAPEUTICS LTD have any charges or mortgages?
NUCLIDE THERAPEUTICS LTD has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.